Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemours Co Director's Dealing 2022

Mar 3, 2022

31561_dirs_2022-03-03_e9605779-ec39-48b5-99b5-6e22bb61632c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-03-01

Reporting Person: Newman Mark (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-01 Common Stock F 1253 $25.98 Disposed 156623.0572 Direct
2022-03-01 Common Stock A 19630 Acquired 176253.057 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-01 Stock Option (Right to Buy) $25.98 A 206268 Acquired 2032-03-01 Common Stock (206268) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2480 Indirect

Footnotes

F1: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2: Includes directly owned shares, restricted stock units and dividend equivalent units.

F3: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023.

F4: These options are scheduled to vest in three equal annual installments beginning on March 1, 2023.